On Nov. 4, 2024, the U.S. Food and Drug Administration (FDA), in collaboration with the Environmental Protection Agency…
On Jul. 19, 2022, Yale scientists announced they had developed a novel Omicron-specific mRNA vaccine that offers superior…
On Oct. 19, 2021, National Science Foundation funded scientists at the Yale School of Public Health and the…
On Mar. 16, 2021, TGen announced a study that suggested ecosystems suitable for harboring ticks that carry debilitating…
On Jan. 28, 2021, Precipio announced that following receipt of an Emergency Use Authorization from the U.S. Food…
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
On Oct. 8, 2020, the National Institutes of Health (NIH) awarded a Research Project Cooperative Agreement grant to…
On Oct. 2, 2020, Yale scientists announced construction of the next-generation human brain PET scanner, the NeuroeXplorer (NX),…
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
On Aug. 15, 2020, a saliva-based laboratory diagnostic test developed by researchers at the Yale School of Public…
On Aug. 15, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
On Aug. 4, 2020, Precipio announced it had completed the internal validation of the U.S. Food and Drug…
On Aug. 4, 2020, Yale University announced it was among the core partners of the new Center for…
On Jul. 31, 2020, Yale researchers reported that differing immune system responses of patients with COVID-19 can help…
On Jul. 30, 2020, Precipio announced it had entered into an agreement with ADS Biotec, based in Omaha,…
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valnevaï¾’s Lyme disease vaccine…
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Oct. 29, 2019, the Yale Science Building officially opened as a central hub for interdisciplinary collaboration on…
On Sept. 11, 2018, Joan Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 2018ï¾ …
On Jan. 19, 2018, Yale evolutionary geneticist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal from the…
On Jan. 12, 2018, Connecticut United for Research Excellence Inc. (CURE) renamed itself BioCT and today is the…
In 2018, Rallybio was founded as a privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients…
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
On Aug. 8, 2016, the National Institute on Drug Abuse announced a five-year grant totaling $11,714,623 to The…
On May 4, 2015, the National Institutes of Health (NIH) dedicated Building 4 in honor of Lowell P….
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…